https://www.avient.com/investor-center/news/polyone-corporation-announces-quarterly-dividend-5
PolyOne
PolyOne
PolyOne's
https://www.avient.com/investor-center/news/polyone-corporation-announces-quarterly-dividend-8
PolyOne
PolyOne
PolyOne's
https://www.avient.com/investor-center/news/polyone-corporation-announces-quarterly-dividend
PolyOne
PolyOne
PolyOne's
https://www.avient.com/investor-center/news/polyone-corporation-announces-quarterly-dividend-0
PolyOne
PolyOne
PolyOne's
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%2520Global%2520Industrial%2520Conference.pdf
PolyOne
Investor Presentation
November 2017
POLYONE CORPORATION 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
In addition, operating income before special items and
adjusted EPS are components of various PolyOne annual and long-term employee
incentive plans
Senior management believes these measures are useful to investors because they allow for comparison to PolyOne's performance in prior periods without the effect of items
that, by their nature, tend to obscure PolyOne's operating results due to the potential variability across periods based on timing, frequency and magnitude.
https://www.avient.com/news/pet-friendly-soft-touch-design-delivers-remarkable-fundraising-dog-toy
About PolyOne
To access PolyOne’s news library online, please go to www.avient.com/news.
Sandy Wagner
Marketing Communications Manager
PolyOne GLS Thermoplastic Elastomers
+1 815-385-8500
sandy.wagner@avient.com
https://www.avient.com/investor-center/news/polyone-declares-quarterly-dividend-increase-30-announces-three-year-dividend-increase-plan
PolyOne Corporation
PolyOne
PolyOne
https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Different tones of amber available on request
—more or less red or yellow and/or lighter
or darker
• Also available in liquid form
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP parts
(Class VI)
- European Pharmacopeia, monograph
3.1.15, USP and elemental analysis
as per ICH Q3D
- USP criteria appearance of solution,
color
• Registered Drug Master File (Type III) by
the FDA
• Food contact compliance established with
FDA/EU*
• YBB00102002-2015 (oral liquid pharmaceutical
PET bottles) compliance support
APPLICATION BULLETIN
* FDA/EU compliance
information available
upon request
Healthcare use limitations apply—see below.
https://www.avient.com/investor-center/news/polyone-presents-solutions-support-circular-economy
PolyOne
PolyOne
PolyOne
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Investor%2520Day%25205-18-15.pdf
PolyOne Corporation Page 4
Agenda
1:00 Introduction Robert M.
Patterson
PolyOne Corporation Page 5
Introduction
Robert M.
Patterson
President and Chief Executive Officer
PolyOne Corporation Page 6
PolyOne Corporation Page 7
Robert M.